Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Amwell is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-08-13SCHEDULE 13G/A
- 10-Q2026-08-04Quarterly report
- 8-K2026-08-04Current report (material event)
- 8-K2026-07-21Current report (material event)
- 8-K2026-07-14Current report (material event)
- 8-K2026-06-22Current report (material event)
- DEFA14A2026-06-09DEFA14A
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 8-K2026-05-12Current report (material event)
- SCHEDULE 13G/A2026-05-11SCHEDULE 13G/A
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- ARS2026-04-23Annual report to holders
- DEFA14A2026-04-23DEFA14A
- DEF 14A2026-04-23Proxy statement
- 8-K2026-04-02Current report (material event)
- S-82026-03-04Employee stock plan
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- 10-K2026-02-12Annual report
- SCHEDULE 13G/A2026-02-12SCHEDULE 13G/A
- 8-K2026-02-12Current report (material event)
- SCHEDULE 13G2026-01-26SCHEDULE 13G
- 8-K2026-01-08Current report (material event)
- 8-K2026-01-02Current report (material event)
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- 10-Q2025-11-04Quarterly report
- 8-K2025-11-04Current report (material event)
- 10-Q2025-08-05Quarterly report
- 8-K2025-08-05Current report (material event)
- 8-K2025-06-17Current report (material event)
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- 10-Q2025-05-01Quarterly report
- 8-K2025-05-01Current report (material event)
- ARS2025-04-23Annual report to holders
- DEFA14A2025-04-23DEFA14A
- DEF 14A2025-04-23Proxy statement
- 8-K2025-03-03Current report (material event)
- S-82025-02-28Employee stock plan
- SCHEDULE 13G/A2025-02-13SCHEDULE 13G/A
- 10-K2025-02-12Annual report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.